AIPLA Direct Live - Patent Center DOCX Filing: What you Need to Know
March 10, 2023 12:30 PM to 1:30 PM
Contact
Credits
No CLE
Registration
The $400 fee for not filing using a DOCX document is fast approaching reality. As of April 3, 2023, if you don’t file a 111 application via Patent Center you will incur the large entity fee of $400. While the USPTO provides weekly webinars on how to file, learn what can go wrong when you least expect it. AIPLA and others have been talking to the USPTO about problems that have been encountered and will continue to be encountered which can lead to errors which you may or may not be able to fix. The discussions have helped lead to delays in implementation of the fee, but those delays will soon be over. We will provide a short how-to-file session and include ways to minimize or eliminate errors without having to pay the additional fee.
Presented by:
- Brad Forrest, Principal, Schwegman Lundberg & Woessner, Minneapolis, MN, and
- Kasie Grover, Paralegal, Schwegman, Lundberg & Woessner, Minneapolis, MN
Free, Member Benefit Webinar. No CLE available.
Speakers
-
Forrest, Brad
Schwegman Lundberg & Woessner | Principal
Brad Forrest is a Principal at Schwegman and is also General Counsel and Chairman. Brad drafts and prosecutes patent applications over a diverse range of high technology, from nanotech and electrical to complex software algorithms, semiconductors, and computer architecture in addition to provide strategic advice regarding patent strategies and opinion work. -
Grover, Kasie
Schwegman Lundberg & Woessner | Paralegal
Kasie Grover has been a paralegal at Schwegman since 2015, assisting with PCT and USPTO filings. During her time at Schwegman, Kasie’s work has predominantly included working with clients outside of the United States to obtain US patents. She also serves on teams relating to medical devices, mechanical engineering and software.
News
-
AIPLA Submits Comments on the World Intellectual Property Organization Riyadh Design Law Treaty
June 24, 2026
Alexandria, VA. June 11, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments on the World Intellectual Property Organization Riyadh Design Law Treaty. -
AIPLA Files Amicus Brief in Arbutus Biopharma Corp. v. Moderna, Inc.
June 22, 2026
Arlington, VA. June 5, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus brief in Arbutus Biopharma Corp. v. Modernatx, Inc. -
Supreme Court Issues Unanimous Decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.
June 4, 2026
On June 4, 2026, the Supreme Court issued a unanimous decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. While the Court reaffirmed existing law on pleading standards, it reversed the Federal Circuit’s decision that had focused on how relevant statements could be understood by medical providers as instructions to infringe. The amicus brief filed by AIPLA on March 27, 2026, advocated for affirmance and cautioned the Court not to change the patent infringement pleading standard or adopt any categorical exemption from inducement for a particular industry. -
AIPLA Views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act”
June 3, 2026
Arlington, VA. June 3, 2026 – The American Intellectual Property Law Association (AIPLA) submitted a letter to the House Judiciary Committee’s Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet outlining its views on H.R. 3269, the “ETHIC Act,” and H.R. 6485, the “Skinny Labels, Big Savings Act.” -
AIPLA Submits Comments to the USPTO on 2026 Supplemental GUI Guidance
May 15, 2026
Arlington, VA. May 12, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO on its Supplemental Guidance for Examination of Design Patent Applications Related to Computer-Generated Interfaces and Icons, issued on March 13, 2026.
